Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
China Close to Approve Fruquintinib for Colon Cancer 7/3/2018
Luye Pharma's Class 1.1 New Analgesic to Start Phase I Trial in C... 6/20/2018
Pharnext's Orphan Drug PXT3003 Granted Priority Review in China 6/14/2018
CStone Initiates Two Pivotal Phase II Studies of Anti-PD-L1 mAb C... 6/13/2018
China Approves 4-Strain Flu Vaccine for 2018 (free) 6/12/2018
Suven Life Sciences Wins Patents in China and USA 6/12/2018
China Approves Indigenously-developed Long-acting Anti-HIV Drug 6/6/2018
Chi-Med Cancer Trial Shows Clinically Meaningful Benefits 6/5/2018
HUYA Bio Reports Latest Progress with Oncology Pipeline (free) 6/5/2018
Innovent Announces Result of its Anti-PD-1 Antibody Study in Hodg... 5/18/2018
Cstone Announces First Patient Dosed with Anti-CTLA-4 Antibody CS... (free) 5/4/2018
HKU Scientists Invent Universal Antibody Drug against HIV/AIDS 4/27/2018
UCB Announces Filing Acceptance with the CNDA for RA Drug CIMZIA 4/26/2018
MSD's HPV Vaccine Gardasil 9 under Review in China 4/25/2018
Merck Group Receives Patent for CRISPR Technology in China 4/24/2018
Sinovac Announces Preliminary Results of Phase III Trial on sIPV 4/19/2018
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients (free) 4/17/2018
JHL Files Clinical Trial Application for Avastin (Bevacizumab) Bi... 4/17/2018
Opdivo (Nivolumab) Improves Survival in Pretreated Chinese NSCLC ... 4/16/2018
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tisl... 4/11/2018
CMBG Announces Positive 48-Week Data of AlloJoin haMPC Knee Osteo... (free) 3/16/2018
Chi-Med On Its Way for First Drug Approval in China This Year 3/13/2018
Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Epitini... 3/9/2018
USFDA Approves Anti-HIV Biologic Made in Taiwan/Mainland China 3/7/2018
US FDA Grants Orphan Drug Status to Yisheng's Biologic for Pancre... (free) 3/1/2018
China Develops A New Intranasal Flu Vaccine 2/27/2018
Elsevier Collaborates with Beijing University of Chinese Medicine... (free) 2/27/2018
China's R&D Spending at Record High in 2017 2/14/2018
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Pati... 2/13/2018
Chi-Med Enrolls 527 Patients in Pivotal Phase III FALUCA Trial of... (free) 2/13/2018
Page:3/4    Total number of articles:96  :[1][2][3][4]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links